Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-504
Closed -$38.1K 1113
2026
Q1
$38.1K Buy
504
+12
+2% +$902 0.02% 506
2025
Q4
$36.6K Hold
492
0.02% 508
2025
Q3
$33.2K Sell
492
-86
-15% -$5.71K 0.02% 538
2025
Q2
$37.7K Buy
578
+436
+307% +$26.1K 0.02% 504
2025
Q1
$8.77K Sell
142
-201
-59% -$13.3K 0.01% 592
2024
Q4
$24.7K Sell
343
-199
-37% -$15.5K 0.01% 564
2024
Q3
$44.2K Buy
542
+416
+330% +$33.3K 0.03% 484
2024
Q2
$9.36K Buy
+126
New +$9.45K 0.01% 596

Other funds holding HOLX

Cromwell Holdings's HOLX Position: Q2 2026 in Review

Cromwell Holdings sold out of Hologic (HOLX) in Q2 2026, closing a stake of 504 shares — an estimated $38.1K sold.

Cromwell Holdings first reported a position in HOLX in Q2 2024 and held it in 8 quarters. The position peaked at $44.2K in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Cromwell Holdings reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Cromwell Holdings sold 504 Hologic shares in Q2 2026, an estimated $38.1K.
  • Cromwell Holdings first reported a position in Hologic in Q2 2024 and held it in 8 quarters.
  • Cromwell Holdings's Hologic position peaked at $44.2K in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.